Seeking Alpha

GenMark Diagnostics (GNMK) falls 6.5% AH on top of 8.35% during the regular session. The company...

GenMark Diagnostics (GNMK) falls 6.5% AH on top of 8.35% during the regular session. The company says it now sees FY13 revenue of ~$30M versus the $35M it originally estimated. GNMK cites "additional uncertainties relating to the future revenue contribution from its largest customer" (previous).
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs